BDBM299143 (6R,8R)-6-(4-(2- (3- (fluoromethyl) azetidin-1- yl)ethoxy) phenyl)-7-((3- fluorooxetan-3- yl)methyl)-6,8- dimethyl-6,7,8,9- tetrahydro-3H- pyrazolo[4,3- f]isoquinoline::US10125135, Example 32

SMILES C[C@@H]1Cc2c(ccc3[nH]ncc23)[C@@](C)(c2ccc(OCCN3CC(CF)C3)cc2)N1CC1(F)COC1

InChI Key InChIKey=JWNQTEWXWPYNGX-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 299143   

TargetEstrogen receptor(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 299143BDBM299143(US10125135, Example 32 | (6R,8R)-6-(4-(2- (3- (flu...)
Affinity DataIC50: 0.670nMAssay Description:The ability of compounds to bind to isolated Estrogen Receptor Alpha Ligand binding domain (ER alpha LBD (GST)) was assessed in competition assays us...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
US Patent